The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Kidney Failure, Chronic

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Kidney Failure, Chronic


Psychiatry related information on Kidney Failure, Chronic


High impact information on Kidney Failure, Chronic


Chemical compound and disease context of Kidney Failure, Chronic


Biological context of Kidney Failure, Chronic


Anatomical context of Kidney Failure, Chronic


Gene context of Kidney Failure, Chronic


Analytical, diagnostic and therapeutic context of Kidney Failure, Chronic


Chemical compound and disease context of Kidney Failure, Chronic


  1. Aquaporins in the kidney: from molecules to medicine. Nielsen, S., Frøkiaer, J., Marples, D., Kwon, T.H., Agre, P., Knepper, M.A. Physiol. Rev. (2002) [Pubmed]
  2. Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. Austin, H.A., Klippel, J.H., Balow, J.E., le Riche, N.G., Steinberg, A.D., Plotz, P.H., Decker, J.L. N. Engl. J. Med. (1986) [Pubmed]
  3. Beta 2-microglobulin amyloidosis in chronic renal failure. Zingraff, J.J., Noel, L.H., Bardin, T., Atienza, C., Zins, B., Drueke, T.B., Kuntz, D. N. Engl. J. Med. (1990) [Pubmed]
  4. Hypercalcemia and elevated 1,25-dihydroxyvitamin D levels in a patient with end-stage renal disease and active tuberculosis. Gkonos, P.J., London, R., Hendler, E.D. N. Engl. J. Med. (1984) [Pubmed]
  5. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. Cowie, C.C., Port, F.K., Wolfe, R.A., Savage, P.J., Moll, P.P., Hawthorne, V.M. N. Engl. J. Med. (1989) [Pubmed]
  6. Defective gallium-transferrin binding in Alzheimer disease and Down syndrome: possible mechanism for accumulation of aluminium in brain. Farrar, G., Altmann, P., Welch, S., Wychrij, O., Ghose, B., Lejeune, J., Corbett, J., Prasher, V., Blair, J.A. Lancet (1990) [Pubmed]
  7. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study. Bakris, G.L., Weir, M.R., Shanifar, S., Zhang, Z., Douglas, J., van Dijk, D.J., Brenner, B.M. Arch. Intern. Med. (2003) [Pubmed]
  8. Dialysis and transplantation affect cerebral abnormalities of end-stage renal disease. Michaelis, T., Videen, J.S., Linsey, M.S., Ross, B.D. Journal of magnetic resonance imaging : JMRI. (1996) [Pubmed]
  9. Liver fibrocystic disease and polydactyly: proposal of a new syndrome. Esmer, C., Alvarez-Mendoza, A., Lieberman, E., Del Castillo, V., Ridaura-Sanz, C. Am. J. Med. Genet. (2001) [Pubmed]
  10. The role of the novel adipocyte-derived hormone adiponectin in human disease. Díez, J.J., Iglesias, P. Eur. J. Endocrinol. (2003) [Pubmed]
  11. Nephrocystin-5, a ciliary IQ domain protein, is mutated in Senior-Loken syndrome and interacts with RPGR and calmodulin. Otto, E.A., Loeys, B., Khanna, H., Hellemans, J., Sudbrak, R., Fan, S., Muerb, U., O'Toole, J.F., Helou, J., Attanasio, M., Utsch, B., Sayer, J.A., Lillo, C., Jimeno, D., Coucke, P., De Paepe, A., Reinhardt, R., Klages, S., Tsuda, M., Kawakami, I., Kusakabe, T., Omran, H., Imm, A., Tippens, M., Raymond, P.A., Hill, J., Beales, P., He, S., Kispert, A., Margolis, B., Williams, D.S., Swaroop, A., Hildebrandt, F. Nat. Genet. (2005) [Pubmed]
  12. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. Brenner, B.M., Cooper, M.E., de Zeeuw, D., Keane, W.F., Mitch, W.E., Parving, H.H., Remuzzi, G., Snapinn, S.M., Zhang, Z., Shahinfar, S. N. Engl. J. Med. (2001) [Pubmed]
  13. Acetaminophen, aspirin, and chronic renal failure. Fored, C.M., Ejerblad, E., Lindblad, P., Fryzek, J.P., Dickman, P.W., Signorello, L.B., Lipworth, L., Elinder, C.G., Blot, W.J., McLaughlin, J.K., Zack, M.M., Nyrén, O. N. Engl. J. Med. (2001) [Pubmed]
  14. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. Lewis, E.J., Hunsicker, L.G., Clarke, W.R., Berl, T., Pohl, M.A., Lewis, J.B., Ritz, E., Atkins, R.C., Rohde, R., Raz, I. N. Engl. J. Med. (2001) [Pubmed]
  15. Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure. Andress, D.L., Norris, K.C., Coburn, J.W., Slatopolsky, E.A., Sherrard, D.J. N. Engl. J. Med. (1989) [Pubmed]
  16. Reduced binding of [3H]1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure. Korkor, A.B. N. Engl. J. Med. (1987) [Pubmed]
  17. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. Ligtenberg, G., Blankestijn, P.J., Oey, P.L., Klein, I.H., Dijkhorst-Oei, L.T., Boomsma, F., Wieneke, G.H., van Huffelen, A.C., Koomans, H.A. N. Engl. J. Med. (1999) [Pubmed]
  18. Cyclosporine-associated chronic nephropathy. Myers, B.D., Ross, J., Newton, L., Luetscher, J., Perlroth, M. N. Engl. J. Med. (1984) [Pubmed]
  19. Aluminum accumulation during treatment with aluminum hydroxide and dialysis in children and young adults with chronic renal disease. Salusky, I.B., Foley, J., Nelson, P., Goodman, W.G. N. Engl. J. Med. (1991) [Pubmed]
  20. Long-term risk of mortality and end-stage renal disease among the elderly after small increases in serum creatinine level during hospitalization for acute myocardial infarction. Newsome, B.B., Warnock, D.G., McClellan, W.M., Herzog, C.A., Kiefe, C.I., Eggers, P.W., Allison, J.J. Arch. Intern. Med. (2008) [Pubmed]
  21. Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial. Brancati, F.L., Whelton, P.K., Randall, B.L., Neaton, J.D., Stamler, J., Klag, M.J. JAMA (1997) [Pubmed]
  22. Thyroid dysfunction in chronic renal failure. A study of the pituitary-thyroid axis and peripheral turnover kinetics of thyroxine and triiodothyronine. Lim, V.S., Fang, V.S., Katz, A.I., Refetoff, S. J. Clin. Invest. (1977) [Pubmed]
  23. Abnormal carbohydrate metabolism in chronic renal failure. The potential role of accelerated glucose production, increased gluconeogenesis, and impaired glucose disposal. Rubenfeld, S., Garber, A.J. J. Clin. Invest. (1978) [Pubmed]
  24. Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man. Brickman, A.S., Coburn, J.W., Friedman, G.R., Okamura, W.H., Massry, S.G., Norman, A.W. J. Clin. Invest. (1976) [Pubmed]
  25. Thyroid hormone metabolism and thyroid diseases in chronic renal failure. Kaptein, E.M. Endocr. Rev. (1996) [Pubmed]
  26. Erythrocyte survival in chronic renal failure. Role of secondary hyperparathyroidism. Akmal, M., Telfer, N., Ansari, A.N., Massry, S.G. J. Clin. Invest. (1985) [Pubmed]
  27. Atrial natriuretic peptide in plasma of volume-overloaded children with chronic renal failure. Rascher, W., Tulassay, T., Lang, R.E. Lancet (1985) [Pubmed]
  28. Plasma-myoinositol concentrations in uraemic neuropathy. Reznek, R.H., Salway, J.G., Thomas, P.K. Lancet (1977) [Pubmed]
  29. Case of the month: March 1998--48 year old man with back pain and weakness. Mourelatus, Z., Goldberg, H., Sinson, G., Quan, D., Lavi, E. Brain Pathol. (1998) [Pubmed]
  30. A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation. Anders, H.J., Vielhauer, V., Frink, M., Linde, Y., Cohen, C.D., Blattner, S.M., Kretzler, M., Strutz, F., Mack, M., Gröne, H.J., Onuffer, J., Horuk, R., Nelson, P.J., Schlöndorff, D. J. Clin. Invest. (2002) [Pubmed]
  31. Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group. Hateboer, N., v Dijk, M.A., Bogdanova, N., Coto, E., Saggar-Malik, A.K., San Millan, J.L., Torra, R., Breuning, M., Ravine, D. Lancet (1999) [Pubmed]
  32. The lack of a functional p21(WAF1/CIP1) gene ameliorates progression to chronic renal failure. Megyesi, J., Price, P.M., Tamayo, E., Safirstein, R.L. Proc. Natl. Acad. Sci. U.S.A. (1999) [Pubmed]
  33. CD151, the first member of the tetraspanin (TM4) superfamily detected on erythrocytes, is essential for the correct assembly of human basement membranes in kidney and skin. Karamatic Crew, V., Burton, N., Kagan, A., Green, C.A., Levene, C., Flinter, F., Brady, R.L., Daniels, G., Anstee, D.J. Blood (2004) [Pubmed]
  34. The polycystic kidney disease 1 gene product mediates protein kinase C alpha-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor AP-1. Arnould, T., Kim, E., Tsiokas, L., Jochimsen, F., Grüning, W., Chang, J.D., Walz, G. J. Biol. Chem. (1998) [Pubmed]
  35. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease. Ifudu, O., Feldman, J., Friedman, E.A. N. Engl. J. Med. (1996) [Pubmed]
  36. Effect of desferrioxamine on removal of aluminum and iron by coated charcoal haemoperfusion and haemodialysis. Chang, T.M., Barre, P. Lancet (1983) [Pubmed]
  37. Hyperglucagonemia in uremia: reversal by renal transplantation. Bilbrey, G.L., Faloona, G.R., White, M.G., Atkins, C., Hull, A.R., Knochel, J.P. Ann. Intern. Med. (1975) [Pubmed]
  38. Thallium stress testing does not predict cardiovascular risk in diabetic patients with end-stage renal disease undergoing cadaveric renal transplantation. Holley, J.L., Fenton, R.A., Arthur, R.S. Am. J. Med. (1991) [Pubmed]
  39. End-stage renal disease risk equations for Hong Kong Chinese patients with type 2 diabetes: Hong Kong Diabetes Registry. Yang, X.L., So, W.Y., Kong, A.P., Clarke, P., Ho, C.S., Lam, C.W., Ng, M.H., Lyu, R.R., Yin, D.D., Chow, C.C., Cockram, C.S., Tong, P.C., Chan, J.C. Diabetologia (2006) [Pubmed]
WikiGenes - Universities